SYSTEMATIC REVIEW article
Front. Med.
Sec. Ophthalmology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1677818
This article is part of the Research TopicPrevention and Treatment Advancements in Diabetic RetinopathyView all 21 articles
The triglyceride-glucose index as a biomarker of diabetic retinopathy: A systematic review and meta-analysis
Provisionally accepted- 1West Kazakhstan Marat Ospanov State Medical University, Aktobe, Fars province, Kazakhstan
- 2Kaspijskij Universitet, Almaty, Kazakhstan
- 3FGBNU Naucno-issledovatel'skij institut glaznyh boleznej imeni M M Krasnova, Moscow, Russia
- 4Al-Farabi Kazakh National University, Almaty, Kazakhstan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has been linked to various diabetic complications. However, its association with diabetic retinopathy (DR) remains inconsistent. We conducted a systematic review and meta-analysis to evaluate the relationship between TyG index levels and the risk of DR. Methods: We searched PubMed, Scopus, and Web of Science from inception to July 2025 for observational studies reporting the association between TyG index and DR in adults with type 1 or type 2 diabetes. Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Agency for Healthcare Research and Quality (AHRQ) checklist and Newcastle-Ottawa Scale. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was evaluated with the I² statistic. Publication bias was assessed via funnel plots and Egger's test. Subgroup and meta-regression analyses were conducted to explore heterogeneity. Results: Sixteen studies with a total of 33,436 participants were included. The pooled OR for the association between higher TyG index and DR was 1.89 (95% CI: 1.27–2.82) when TyG was treated as a categorical variable, and 1.57 (95% CI: 1.25–1.98) when treated as continuous. Significant heterogeneity was observed (I² > 87%). Subgroup analyses revealed stronger associations in studies with smaller sample sizes and higher male proportions. Meta-regression showed that male proportion accounted for 48.71% of the heterogeneity. In categorical analyses, funnel-plot asymmetry and Egger's test indicated small-study effects; after trim-and-fill adjustment the pooled effect attenuated and was no longer significant, suggesting sensitivity to publication bias. Conclusions: While higher TyG levels correlate with DR—particularly when modeled continuously—the signal is heterogeneity-and bias-sensitive in categorical analyses. Our moderator analyses newly indicate a sex-composition effect, and the current lack of harmonized clinical TyG thresholds limits immediate translation.
Keywords: Triglyceride-glucose index, TyG, TyG index, Diabetes Mellitus, Diabetic Retinopathy, Meta-analysis
Received: 01 Aug 2025; Accepted: 09 Oct 2025.
Copyright: © 2025 Amirashov, Balmukhanova, Koishybayev, Petrachkov, Koishybayeva, Balmukhanova, Mussin and Tamadon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Amin Tamadon, amintamaddon@yahoo.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.